Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

Athletes need effective management of skin disorders for their performance and well-being.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Some medications can cause hair loss, and it's important to track when the hair loss starts after taking a new medication.

Effective symptom management in IBD improves quality of life and prevents complications.

Some blood thinners can cause hair loss, but switching medications can stop it.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Cyclosporin doesn't stop hair loss.

A man's rash caused by Finasteride improved after stopping the drug and starting new treatments.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Microbial biosurfactants could be a safer and environmentally friendly alternative to chemical surfactants in cosmetics.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Different rheumatological diseases can cause specific skin problems.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Some chemicals absorbed through the skin can cause serious health problems.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.